Kari G Rabe1, Maria A Stevens2, Amanda Toledo Hernández3, Shruti Chandra4, Joleen M Hubbard5, Jennifer L Kemppainen6, Shounak Majumder7, Gloria M Petersen8. 1. Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. 2. Division of Health Care Policy and Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN. 3. School of Medicine, Medical Science Campus, University of Puerto Rico, San Juan, Puerto Rico. 4. Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. 5. Department of Medical Oncology, Mayo Clinic, Rochester, MN. 6. Department of Clinical Genomics, Mayo Clinic, Rochester, MN. 7. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN. 8. Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. Electronic address: Petersen.Gloria@mayo.edu.
Abstract
PURPOSE: Pancreatic cancer (PC) risk is increased in families, but PC risk and risk perception have been understudied when both parents have cancer. METHODS: An unbiased method defining cancer triads (proband with PC and both parents with cancer) in a prospective registry estimated risk of PC to probands' siblings in triad group 1 (no parent with PC), group 2 (1 parent with PC), and group 3 (both parents with PC). We estimated standardized incidence ratios (SIRs) using a Surveillance, Epidemiology, and End Results (SEER) reference. We also estimated the risk when triad probands carried germline pathogenic/likely pathogenic variants in any of the 6 PC-associated genes (ATM, BRCA1, BRCA2, CDKN2A, MLH1, and TP53). PC risk perception/concern was surveyed in siblings and controls. RESULTS: Risk of PC was higher (SIR = 3.5; 95% CI = 2.2-5.2) in 933 at-risk siblings from 297 triads. Risk increased by triad group: 2.8 (95% CI = 1.5-4.5); 4.5 (95% CI = 1.6-9.7); and 21.2 (95% CI = 4.3-62.0). SIR in variant-negative triads was 3.0 (95% CI = 1.6-5.0), whereas SIR in variant-positive triads was 10.0 (95% CI = 3.2-23.4). Siblings' perceived risk/concern of developing PC increased by triad group. CONCLUSION: Sibling risks were 2.8- to 21.2-fold higher than that of the general population. Positive variant status increased the risk in triads. Increasing number of PC cases in a triad was associated with increased concern and perceived PC risk.
PURPOSE: Pancreatic cancer (PC) risk is increased in families, but PC risk and risk perception have been understudied when both parents have cancer. METHODS: An unbiased method defining cancer triads (proband with PC and both parents with cancer) in a prospective registry estimated risk of PC to probands' siblings in triad group 1 (no parent with PC), group 2 (1 parent with PC), and group 3 (both parents with PC). We estimated standardized incidence ratios (SIRs) using a Surveillance, Epidemiology, and End Results (SEER) reference. We also estimated the risk when triad probands carried germline pathogenic/likely pathogenic variants in any of the 6 PC-associated genes (ATM, BRCA1, BRCA2, CDKN2A, MLH1, and TP53). PC risk perception/concern was surveyed in siblings and controls. RESULTS: Risk of PC was higher (SIR = 3.5; 95% CI = 2.2-5.2) in 933 at-risk siblings from 297 triads. Risk increased by triad group: 2.8 (95% CI = 1.5-4.5); 4.5 (95% CI = 1.6-9.7); and 21.2 (95% CI = 4.3-62.0). SIR in variant-negative triads was 3.0 (95% CI = 1.6-5.0), whereas SIR in variant-positive triads was 10.0 (95% CI = 3.2-23.4). Siblings' perceived risk/concern of developing PC increased by triad group. CONCLUSION: Sibling risks were 2.8- to 21.2-fold higher than that of the general population. Positive variant status increased the risk in triads. Increasing number of PC cases in a triad was associated with increased concern and perceived PC risk.
Authors: Christine Maheu; Andrea Vodermaier; Heidi Rothenmund; Steve Gallinger; Paola Ardiles; Kara Semotiuk; Spring Holter; Saumea Thayalan; Mary Jane Esplen Journal: Fam Cancer Date: 2010-12 Impact factor: 2.375
Authors: Nora B Henrikson; Elizabeth M Webber; Katrina A Goddard; Aaron Scrol; Margaret Piper; Marc S Williams; Doris T Zallen; Ned Calonge; Theodore G Ganiats; A Cecile J W Janssens; Ann Zauber; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Evelyn P Whitlock Journal: Genet Med Date: 2015-01-15 Impact factor: 8.822
Authors: Andrew McGuigan; Paul Kelly; Richard C Turkington; Claire Jones; Helen G Coleman; R Stephen McCain Journal: World J Gastroenterol Date: 2018-11-21 Impact factor: 5.742